DK570589A - Hybridproteiner - Google Patents

Hybridproteiner

Info

Publication number
DK570589A
DK570589A DK570589A DK570589A DK570589A DK 570589 A DK570589 A DK 570589A DK 570589 A DK570589 A DK 570589A DK 570589 A DK570589 A DK 570589A DK 570589 A DK570589 A DK 570589A
Authority
DK
Denmark
Prior art keywords
hybrid proteins
proteins
hybrid
Prior art date
Application number
DK570589A
Other languages
Danish (da)
English (en)
Other versions
DK570589D0 (da
Inventor
Grace W Ju
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK570589D0 publication Critical patent/DK570589D0/da
Publication of DK570589A publication Critical patent/DK570589A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK570589A 1988-11-17 1989-11-14 Hybridproteiner DK570589A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27235688A 1988-11-17 1988-11-17

Publications (2)

Publication Number Publication Date
DK570589D0 DK570589D0 (da) 1989-11-14
DK570589A true DK570589A (da) 1990-05-18

Family

ID=23039446

Family Applications (1)

Application Number Title Priority Date Filing Date
DK570589A DK570589A (da) 1988-11-17 1989-11-14 Hybridproteiner

Country Status (13)

Country Link
EP (1) EP0369316A3 (fr)
JP (1) JPH02273193A (fr)
AU (1) AU4474589A (fr)
CA (1) CA2002854A1 (fr)
DK (1) DK570589A (fr)
FI (1) FI895456A7 (fr)
HU (1) HUT52154A (fr)
IL (1) IL92316A0 (fr)
MC (1) MC2072A1 (fr)
NO (1) NO894573L (fr)
PT (1) PT92335A (fr)
YU (1) YU219289A (fr)
ZA (1) ZA898139B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0406857B1 (fr) * 1989-07-07 1995-05-24 Takeda Chemical Industries, Ltd. Protéines et leur production
FR2653020B1 (fr) * 1989-10-17 1993-03-26 Roussel Uclaf Utilisation d'un polypeptide ayant l'activite de l'interleukine 2 humaine pour la preparation de compositions pharmaceutiques destinees au traitement des leucemies.
US5238823A (en) * 1990-08-22 1993-08-24 Veterinary Infectious Disease Organization Interleukin-2-leukotoxin gene fusions and uses thereof
US5273889A (en) * 1990-08-22 1993-12-28 University Of Saskatchewan Gamma-iterferon-leukotoxin gene fusions and uses thereof
US5594107A (en) * 1990-08-22 1997-01-14 University Of Saskatchewan Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon
JPH06502301A (ja) * 1990-08-29 1994-03-17 サントル　オスピタリエ　レジオナル　デ　ナント 安定タンパク質コアに結合されたタンパク質ポリリガンド
US5571507A (en) * 1992-02-25 1996-11-05 Seragen, Inc. Methods of treating diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210634A (en) * 1983-12-23 1989-05-29 Hoffmann La Roche Purification of recombinant human interleukin - 2; pharmaceutical compositions
DE3537461A1 (de) * 1985-10-22 1987-04-23 Hoechst Ag Derivat des interleukin-2, seine herstellung und verwendung
US4892827A (en) * 1986-09-24 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Recombinant pseudomonas exotoxins: construction of an active immunotoxin with low side effects

Also Published As

Publication number Publication date
AU4474589A (en) 1990-05-24
MC2072A1 (fr) 1990-10-03
ZA898139B (en) 1990-08-29
EP0369316A2 (fr) 1990-05-23
IL92316A0 (en) 1990-07-26
FI895456A0 (fi) 1989-11-16
PT92335A (pt) 1990-05-31
EP0369316A3 (fr) 1990-11-22
HUT52154A (en) 1990-06-28
JPH02273193A (ja) 1990-11-07
FI895456A7 (fi) 1990-05-18
YU219289A (en) 1991-10-31
HU895908D0 (en) 1990-02-28
DK570589D0 (da) 1989-11-14
NO894573L (no) 1990-05-18
CA2002854A1 (fr) 1990-05-17
NO894573D0 (no) 1989-11-16

Similar Documents

Publication Publication Date Title
DK540289A (da) Protein
DK97790A (da) Renin-inhiberende peptider
FI895346A7 (fi) Sitoutuvia proteiineja
DK275788D0 (da) Protein
FI875324L (fi) Hybridproteiner.
DK354487D0 (da) Oncogen-relaterede peptider
DK531986D0 (da) Peptider
FI900550A7 (fi) Hybridiproteiineja
DK395288D0 (da) Proteiner
FI893451A7 (fi) Uudet proteiinit
FI895844A7 (fi) Hyytymistä estävät peptidit
DK219589A (da) Klaebemiddel
DK570589D0 (da) Hybridproteiner
FI912412A7 (fi) HDL-sitovat proteiinit
DK345087D0 (da) Protein
DK354989D0 (da) Modificerede proteiner
DK171790A (da) Koeretoej
DK284489A (da) Fusionsproteiner
IT9020676A1 (it) Disposizione ibrida
BR8902036A (pt) Veiculo
FI885663A7 (fi) Hybridipatja
NO900470D0 (no) Hybride proteiner.
DK101587D0 (da) Peptider
DK595689D0 (da) Peptider
DK51188D0 (da) Peptider

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment